Author

C. Lavine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 2 Organism:virus· 2 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Gautam· 2 shared B. Chen· 2 shared D. Wesemann· 2 shared H. Peng· 2 shared H. Zhu· 2 shared J. Lu· 2 shared J. Zhang· 2 shared K. Anand· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Gautam

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike

J. Zhang, T. Weichun, H. Gao, C. Lavine, W. Shi, H. Peng, H. Zhu, K. Anand, M. Kosikova, H. J. Kwon, P. Tong, A. Gautam, S. Rits-Volloch, S. Wang, M. L. Mayer, , B. Chen

This study characterizes the structural, functional, and antigenic properties of SARS-CoV-2 Omicron BA.2 spike protein and compares its replication efficiency with previous variants.

bioRxiv · Apr 28, 2022 · PreprintMicrobiology

Structural and functional impact by SARS-CoV-2 Omicron spike mutations

J. Zhang, Y. Cai, C. Lavine, H. Peng, H. Zhu, K. Anand, P. Tong, A. Gautam, M. Mayer, S. Rits-Volloch, S. Wang, P. Sliz, D. Wesemann, W. Yang, M. Seaman, , B. Chen

This study examines the structural, functional, and antigenic properties of the SARS-CoV-2 Omicron spike protein, revealing its enhanced immune evasion and altered fusogenic capability due to mutations.

bioRxiv · Jan 11, 2022Biochemistry

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against primary African isolates

J. C. C. Lorenzi, P. Mendoza, Y. Z. Cohen, L. Nogueira, C. Lavine, J. Sapiente, M. Seaman, M. Wiatr, N. R. Mugo, A. Mujugira, S. Delany, J. R. Lingappa, C. Celum, M. Caskey, M. C. Nussenzweig

This study evaluates the neutralizing activity of 9 anti-HIV-1 bNAbs against primary African isolates, finding reduced potency and breadth compared to pseudotyped viruses.

bioRxiv · Sep 24, 2020Immunology